Skip to main content
Erschienen in: Abdominal Radiology 6/2021

02.01.2021 | Pelvis

Useful preoperative examination findings to classify the grade of ovarian primary mucinous tumor

verfasst von: Ayumi Ohya, Fumihito Ichinohe, Hisanori Matoba, Hisanori Kobara, Yasunari Fujinaga

Erschienen in: Abdominal Radiology | Ausgabe 6/2021

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To evaluate various imaging features on magnetic resonance imaging (MRI) and tumor markers and their utility to assess various grades of ovarian primary mucinous tumors (OPMTs): benign, borderline, or malignant.

Methods

Ninety-five pathologically diagnosed OPMTs [53 benign, 24 borderline malignant (BM), and 18 malignant] were selected in this retrospective study. MRI features of the ovarian mass, namely the maximum diameter, honeycomb loculi, solid components (SC), stained-glass pattern, and signal intensity of the cyst on T1- (T1WI) and T2-weighted imaging (T2WI) with/without fat suppression, and preoperative STMs, namely carcinoembryonic antigen (CEA), carbohydrate antigen (CA) 19-9, and CA125, were compared between the three tumor grades using univariate analysis. We also analyzed the findings to estimate the pathological diagnosis using classification tree (CT) analysis.

Results

Maximum diameter, honeycomb loculi, SC, stained-glass pattern, signal intensity of the cyst [hyperintensity on both T1WI and T2WI (T1-hyper/T2-hyper), and hyperintense on T1WI and hypointense on T2WI (T1-hyper/T2-hypo)], and CEA and CA 19-9 concentrations were significantly different between the three tumor grades (p < 0.05). The concordance rate with the pathological diagnosis was the highest with diagnosis by the CT comprising T1-hyper/T2-hypo, CEA, and CA 19-9 and by the CT comprising T1-hyper/T2-hypo, CEA, and SC.

Conclusion

Four types of findings were important for OPMT grading. Lesions negative for both T1-hyper/T2-hypo and CEA suggest benign; lesions positive for T1-hyper/T2-hypo and negative for CA 19-9 or SC suggest BM; and lesions negative for T1-hyper/T2-hypo and positive for CEA, or positive for both T1-hyper/T2-hypo and CA 19-9 or SC suggest malignancy.
Literatur
1.
Zurück zum Zitat Kurman RJ, Carcangiu ML, Herrington S, Young RH (2014) WHO Classification of Tumours of Female Reproductive Organs 4th ed. IARC Publications, Lyon Kurman RJ, Carcangiu ML, Herrington S, Young RH (2014) WHO Classification of Tumours of Female Reproductive Organs 4th ed. IARC Publications, Lyon
2.
Zurück zum Zitat Okamoto Y, Tanaka YO, Tsunoda H, Yoshikawa H, Minami M (2007) Malignant or borderline mucinous cystic neoplasms have a larger number of loculi than mucinous cystadenoma: a retrospective study with MR. J Magn Reson Imaging 26:94–99CrossRef Okamoto Y, Tanaka YO, Tsunoda H, Yoshikawa H, Minami M (2007) Malignant or borderline mucinous cystic neoplasms have a larger number of loculi than mucinous cystadenoma: a retrospective study with MR. J Magn Reson Imaging 26:94–99CrossRef
3.
Zurück zum Zitat Ma FH, Zhao SH, Qiang JW, Zhang GF, Wang XZ, Wang L (2014) MRI appearances of mucinous borderline ovarian tumors: pathological correlation. J Magn Reson Imaging 40:745–751CrossRef Ma FH, Zhao SH, Qiang JW, Zhang GF, Wang XZ, Wang L (2014) MRI appearances of mucinous borderline ovarian tumors: pathological correlation. J Magn Reson Imaging 40:745–751CrossRef
4.
Zurück zum Zitat Zhao SH, Qiang JW, Zhang GF, Wang SJ, Qiu HY, Wang L (2014) MRI in differentiating ovarian borderline from benign mucinous cystadenoma: pathological correlation. J Magn Reson Imaging 39:162–166CrossRef Zhao SH, Qiang JW, Zhang GF, Wang SJ, Qiu HY, Wang L (2014) MRI in differentiating ovarian borderline from benign mucinous cystadenoma: pathological correlation. J Magn Reson Imaging 39:162–166CrossRef
5.
Zurück zum Zitat Neunteufel W, Breitenecker G (1989) Tissue expression of CA 125 in benign and malignant lesions of ovary and fallopian tube: a comparison with CA 19-9 and CEA. Gynecol Oncol 32:297–302CrossRef Neunteufel W, Breitenecker G (1989) Tissue expression of CA 125 in benign and malignant lesions of ovary and fallopian tube: a comparison with CA 19-9 and CEA. Gynecol Oncol 32:297–302CrossRef
6.
Zurück zum Zitat Tanaka YO, Okada S, Satoh T, Matsumoto K, Oki A, Saida T, Yoshikawa H, Minami M (2016) Differentiation of epithelial ovarian cancer subtypes by use of imaging and clinical data: a detailed analysis. Cancer Imaging 16:3CrossRef Tanaka YO, Okada S, Satoh T, Matsumoto K, Oki A, Saida T, Yoshikawa H, Minami M (2016) Differentiation of epithelial ovarian cancer subtypes by use of imaging and clinical data: a detailed analysis. Cancer Imaging 16:3CrossRef
7.
Zurück zum Zitat Ye C, Ito K, Komatsu Y, Takagi H (1994) Extremely high levels of CA19-9 and CA125 antigen in benign mucinous ovarian cystadenoma. Gynecol Oncol 52:267–271CrossRef Ye C, Ito K, Komatsu Y, Takagi H (1994) Extremely high levels of CA19-9 and CA125 antigen in benign mucinous ovarian cystadenoma. Gynecol Oncol 52:267–271CrossRef
8.
Zurück zum Zitat Chen F, Shen J, Wang J, Cal P, Huang Y (2018) Clinical analysis of four serum markers in 458 patients with ovarian tumors: diagnostic value of the combined use of HE4, CA125, CA19-9, and CEA in ovarian tumors. Cancer Manag Res 10:1313–1318CrossRef Chen F, Shen J, Wang J, Cal P, Huang Y (2018) Clinical analysis of four serum markers in 458 patients with ovarian tumors: diagnostic value of the combined use of HE4, CA125, CA19-9, and CEA in ovarian tumors. Cancer Manag Res 10:1313–1318CrossRef
9.
Zurück zum Zitat Lin W, Cao D, Shen K (2018) Prognostic significance of preoperative serum CEA in primary mucinous ovarian carcinoma: a retrospective cohort study. Cancer Manag Res 10:6913–6920CrossRef Lin W, Cao D, Shen K (2018) Prognostic significance of preoperative serum CEA in primary mucinous ovarian carcinoma: a retrospective cohort study. Cancer Manag Res 10:6913–6920CrossRef
10.
Zurück zum Zitat Santotoribio JD, Garcia-de la Torre A, Cañavate-Solano C, Arce-Matute F, Sanchez-del Pino MJ, Perez-Ramos S (2016) Cancer antigens 19.9 and 125 as tumor makers in patients with mucinous ovarian tumors. Eur J Gynaecol Oncol 37:26–29PubMed Santotoribio JD, Garcia-de la Torre A, Cañavate-Solano C, Arce-Matute F, Sanchez-del Pino MJ, Perez-Ramos S (2016) Cancer antigens 19.9 and 125 as tumor makers in patients with mucinous ovarian tumors. Eur J Gynaecol Oncol 37:26–29PubMed
12.
Zurück zum Zitat Renzulli M, Biselli M, Brocchi S, et al (2018) New hallmark of hepatocellular carcinoma, early hepatocellular carcinoma and high-grade dysplastic nodules on Gd-EOB-DTPA MRI in patients with cirrhosis: a new diagnostic algorithm. Gut 67:1674–1682CrossRef Renzulli M, Biselli M, Brocchi S, et al (2018) New hallmark of hepatocellular carcinoma, early hepatocellular carcinoma and high-grade dysplastic nodules on Gd-EOB-DTPA MRI in patients with cirrhosis: a new diagnostic algorithm. Gut 67:1674–1682CrossRef
13.
Zurück zum Zitat Jansen MJA, Kuijf HJ, Veldhuis WB, Wessels FJ, Viergever MA, Pluim JPW (2019) Automatic classification of focal liver lesions based on MRI and risk factors. PLoS ONE 14:e0217053CrossRef Jansen MJA, Kuijf HJ, Veldhuis WB, Wessels FJ, Viergever MA, Pluim JPW (2019) Automatic classification of focal liver lesions based on MRI and risk factors. PLoS ONE 14:e0217053CrossRef
14.
Zurück zum Zitat Tanaka YO, Nishida M, Kurosaki Y, Itai Y, Tsunoda H, Kubo T (1999) Differential diagnosis of gynecological “stained grass” tumours on MRI. Br J Radiol 72:414–420CrossRef Tanaka YO, Nishida M, Kurosaki Y, Itai Y, Tsunoda H, Kubo T (1999) Differential diagnosis of gynecological “stained grass” tumours on MRI. Br J Radiol 72:414–420CrossRef
15.
Zurück zum Zitat Tanaka Y, Nakai G, Yamamura K, Yamamoto K, Narumi Y, Ohmichi M (2019) Analysis of MRI values and hemoglobin and total protein concentrations of cystic ovarian tumors. J Magn Reson Imaging 49:1133–1140CrossRef Tanaka Y, Nakai G, Yamamura K, Yamamoto K, Narumi Y, Ohmichi M (2019) Analysis of MRI values and hemoglobin and total protein concentrations of cystic ovarian tumors. J Magn Reson Imaging 49:1133–1140CrossRef
16.
Zurück zum Zitat Anzalone N, Scotti R, Riva R (2004) Neuroradiologic differential diagnosis of cerebral intraparenchymal hemorrhage. Neurol Sci 25:S3–S5CrossRef Anzalone N, Scotti R, Riva R (2004) Neuroradiologic differential diagnosis of cerebral intraparenchymal hemorrhage. Neurol Sci 25:S3–S5CrossRef
17.
Zurück zum Zitat Hayashi Y, Tachibana O, Muramatsu N, et al (1999) Rathke cleft cyst: MR and biomedical analysis of cyst content. J Comput Assist Tomogr 23:34–38CrossRef Hayashi Y, Tachibana O, Muramatsu N, et al (1999) Rathke cleft cyst: MR and biomedical analysis of cyst content. J Comput Assist Tomogr 23:34–38CrossRef
18.
Zurück zum Zitat Ghossain MA, Buy JN, Ligneres C, et al (1991) Epithelial tumors of the ovary: comparison of MR and CT findings. Radiology 181:863–870CrossRef Ghossain MA, Buy JN, Ligneres C, et al (1991) Epithelial tumors of the ovary: comparison of MR and CT findings. Radiology 181:863–870CrossRef
19.
Zurück zum Zitat Outwater EK, Huang AB, Dunton CJ, Talerman A, Capuzzi DM (1997) Papillary projections in ovarian neoplasms: appearance on MRI. J Magn Reson Imaging 7:689–695CrossRef Outwater EK, Huang AB, Dunton CJ, Talerman A, Capuzzi DM (1997) Papillary projections in ovarian neoplasms: appearance on MRI. J Magn Reson Imaging 7:689–695CrossRef
Metadaten
Titel
Useful preoperative examination findings to classify the grade of ovarian primary mucinous tumor
verfasst von
Ayumi Ohya
Fumihito Ichinohe
Hisanori Matoba
Hisanori Kobara
Yasunari Fujinaga
Publikationsdatum
02.01.2021
Verlag
Springer US
Erschienen in
Abdominal Radiology / Ausgabe 6/2021
Print ISSN: 2366-004X
Elektronische ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-020-02918-4

Weitere Artikel der Ausgabe 6/2021

Abdominal Radiology 6/2021 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.